Primary non-alcoholic fatty liver disease in hypertensive patients.

about

Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications.

P2860

Q36151646-CF806EB7-5084-4004-A1FE-9474365CCC20 Q37385527-3D1312AC-5019-4D3A-BEC2-C430689BD5E4

P2860

Primary non-alcoholic fatty liver disease in hypertensive patients.

Item

http://www.wikidata.org/entity/Q36984599

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Primary non-alcoholic fatty liver disease in hypertensive patients.

@en

type

Item

label

Primary non-alcoholic fatty liver disease in hypertensive patients.

@en

prefLabel

Primary non-alcoholic fatty liver disease in hypertensive patients.

@en

P1476

Primary non-alcoholic fatty liver disease in hypertensive patients

@en

P2093

Luminita Latea

http://www.w3.org/2001/XMLSchema#string

Stefania Negrea

http://www.w3.org/2001/XMLSchema#string

P2860

Twenty-four hour ambulatory blood pressure in the Hypertension Optimal Treatment (HOT) study

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

Nondipping blood pressure patterns among individuals with essential hypertension: a review of the literature.

Non-alcoholic fatty liver disease: a brief review.

Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome.

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study

Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance

Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Insulin resistance in hypertension and cardiovascular disease.

P304

325-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4066/AMJ.2013.1648

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sorana Bolboacă

P577

2013-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23837080

http://www.w3.org/2001/XMLSchema#string

P932

3702137

http://www.w3.org/2001/XMLSchema#string

Primary non-alcoholic fatty liver disease in hypertensive patients.

about

P2860

P2860

Primary non-alcoholic fatty liver disease in hypertensive patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932